topotecan has been researched along with Esophagitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, N; Chen, D; Feng, Q; Hui, Z; Ji, Z; Liang, J; Liu, L; Lyu, J; Wang, J; Wang, L; Wang, X; Xiao, Z; Yin, W; Zhang, H; Zhou, Z | 1 |
| Berlin, J; Boothman, D; Forouzannia, A; Hutson, P; Mehta, M; Schiller, J; Storer, B; Wilding, G | 1 |
1 trial(s) available for topotecan and Esophagitis
| Article | Year |
|---|---|
A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Diarrhea; Esophagitis; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Radiation-Sensitizing Agents; Thoracic Neoplasms; Thrombocytopenia; Topotecan; Treatment Outcome | 2004 |
1 other study(ies) available for topotecan and Esophagitis
| Article | Year |
|---|---|
[Outcome of concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cyclophosphamide; Esophagitis; Humans; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Topotecan | 2015 |